Pulse Biosciences, Inc. (PLSE) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$25.27M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$19.15M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$20.37M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$20.27M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$25.27M | (m) | $434.00K | (m) | $90.00K* | -$18.71M* | (m) | $16.98M | $8.46M | (m) |
| 2026-03-31 | Reported | (m) | -$19.15M | (m) | $401.00K | (m) | $33.00K | -$14.60M | (m) | $12.59M | $6.59M | (m) |
| 2025-09-30 | Reported | (m) | -$20.37M | (m) | $86.00K | (m) | $62.00K* | -$13.04M* | (m) | $11.39M | $8.78M | (m) |
| 2025-06-30 | Reported | (m) | -$20.27M | (m) | $0.00 | (m) | $103.00K* | -$12.81M* | (m) | $12.09M | $8.19M | $0.00 |
| 2025-03-31 | Reported | (m) | -$18.04M | (m) | $0.00 | (m) | $45.00K | -$13.52M | (m) | $10.31M | $7.73M | $0.00 |
| 2024-09-30 | Reported | (m) | -$13.65M | (m) | $0.00 | (m) | $38.00K* | -$9.02M* | (m) | $7.70M | $5.95M | $0.00 |
| 2024-06-30 | Reported | (m) | -$11.73M | (m) | $0.00 | (m) | $29.00K* | -$8.39M* | (m) | $7.23M | (m) | $0.00 |
| 2024-03-31 | Reported | (m) | -$10.62M | (m) | $0.00 | (m) | $5.00K | -$9.78M | (m) | $6.74M | (m) | $0.00 |
| 2023-09-30 | Reported | (m) | -$11.25M | (m) | $0.00 | (m) | $23.00K* | -$10.49M* | (m) | $7.47M | (m) | $0.00 |
| 2023-06-30 | Reported | (m) | -$10.23M | (m) | $0.00 | (m) | $16.00K* | -$9.20M* | (m) | $6.70M | (m) | $0.00 |
| 2023-03-31 | Reported | (m) | -$9.56M | (m) | $0.00 | (m) | $39.00K | -$6.57M | (m) | $5.83M | (m) | $0.00 |
| 2022-09-30 | Reported | (m) | -$18.02M | (m) | $0.00 | (m) | $62.00K* | -$10.63M* | (m) | $4.52M | (m) | $0.00 |
| 2022-06-30 | Reported | (m) | -$14.01M | (m) | $265.00K | (m) | $19.00K* | -$12.82M* | (m) | $5.46M | (m) | $0.00 |
| 2022-03-31 | Reported | (m) | -$17.27M | (m) | $444.00K | (m) | $279.00K | -$15.59M | (m) | $6.77M | (m) | $0.00 |
| 2021-09-30 | Reported | (m) | -$14.27M | (m) | $574.00K | (m) | $157.00K* | -$13.35M* | (m) | $6.46M | (m) | (m) |
| 2021-06-30 | Reported | (m) | -$14.81M | (m) | (m) | (m) | $95.00K* | -$16.37M* | (m) | $7.46M | (m) | (m) |
| 2021-03-31 | Reported | (m) | -$18.52M | (m) | (m) | (m) | $51.00K | -$11.69M | (m) | $9.06M | (m) | (m) |
| 2020-09-30 | Reported | (m) | -$12.90M | (m) | (m) | (m) | $62.00K* | -$8.55M* | (m) | $6.97M | (m) | (m) |
| 2019-12-31 | Reported | (m) | -$13.79M | (m) | (m) | (m) | (m) | (m) | (m) | $6.59M | (m) | (m) |
| 2019-09-30 | Reported | (m) | -$11.75M | (m) | (m) | (m) | $533.00K* | -$7.96M* | (m) | $6.19M | (m) | (m) |
| 2019-06-30 | Reported | (m) | -$11.36M | (m) | (m) | (m) | $67.00K* | -$9.69M* | (m) | $6.34M | (m) | (m) |
| 2019-03-31 | Reported | (m) | -$10.08M | (m) | (m) | (m) | $45.00K | -$7.33M | (m) | $5.84M | (m) | (m) |
| 2018-12-31 | Reported | (m) | -$8.95M | (m) | (m) | (m) | (m) | (m) | (m) | $5.08M | (m) | (m) |
| 2018-09-30 | Reported | (m) | -$10.76M | (m) | (m) | (m) | $72.00K* | -$6.85M* | (m) | $5.04M | (m) | (m) |
| 2018-06-30 | Reported | (m) | -$9.16M | (m) | (m) | (m) | $137.00K* | -$5.72M* | (m) | $3.96M | (m) | (m) |
| 2018-03-31 | Reported | (m) | -$8.67M | (m) | (m) | (m) | $34.00K | -$5.02M | (m) | $3.17M | (m) | (m) |
| 2017-12-31 | Reported | (m) | -$8.70M | (m) | (m) | (m) | (m) | (m) | (m) | $2.86M | (m) | (m) |
| 2017-09-30 | Reported | (m) | -$7.49M | (m) | (m) | (m) | -$57.00K* | -$3.42M* | (m) | $2.92M | (m) | (m) |
| 2017-06-30 | Reported | (m) | -$6.18M | (m) | (m) | (m) | (m) | -$1.21M* | (m) | $2.13M | (m) | (m) |
| 2017-03-31 | Reported | (m) | -$3.20M | (m) | (m) | (m) | (m) | -$2.50M | (m) | $1.73M | (m) | (m) |
| 2016-12-31 | Reported | (m) | -$2.81M | (m) | (m) | (m) | (m) | (m) | (m) | $1.65M | (m) | (m) |
| 2016-09-30 | Reported | (m) | -$2.77M | (m) | (m) | (m) | $3.00K* | (m) | (m) | $1.55M | (m) | (m) |
| 2016-06-30 | Reported | (m) | -$2.26M | (m) | (m) | (m) | $22.00K* | (m) | (m) | $1.43M | (m) | (m) |
| 2016-03-31 | Reported | (m) | -$1.68M | (m) | (m) | (m) | $39.00K | (m) | (m) | $874.00K | (m) | (m) |
| 2015-12-31 | Reported | (m) | -$1.53M | (m) | (m) | (m) | (m) | (m) | (m) | $951.00K | (m) | -$518.00K |
| 2015-09-30 | Reported | (m) | -$1.23M | (m) | (m) | (m) | $39.00K* | (m) | (m) | $659.00K | (m) | -$483.00K |
| 2015-06-30 | Reported | (m) | -$956.00K | (m) | (m) | (m) | (m) | (m) | (m) | $547.00K | (m) | -$357.00K |
| 2015-03-31 | Reported | (m) | -$743.00K | (m) | (m) | (m) | (m) | (m) | (m) | $421.00K | (m) | -$299.00K |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$76.94M | (m) | $350.00K | (m) | $315.00K | -$54.12M | (m) | $44.72M | $32.03M | $0.00 |
| 2024-12-31 | Reported | (m) | -$56.26M | (m) | $0.00 | (m) | $125.00K | -$36.34M | (m) | $32.34M | $23.92M | $0.00 |
| 2023-12-31 | Reported | (m) | -$43.57M | (m) | $0.00 | (m) | $121.00K | -$33.04M | (m) | $27.80M | (m) | $0.00 |
| 2022-12-31 | Reported | (m) | -$58.06M | (m) | $700.00K | (m) | $401.00K | -$47.01M | (m) | $20.84M | (m) | $0.00 |
| 2021-12-31 | Reported | (m) | -$63.01M | (m) | $1.42M | (m) | $437.00K | -$54.10M | $600.00K | $28.64M | (m) | $0.00 |
| 2020-12-31 | Reported | (m) | -$49.97M | (m) | $0.00 | (m) | $441.00K | -$35.37M | $500.00K | $26.44M | (m) | $0.00 |
| 2019-12-31 | Reported | (m) | -$47.95M | (m) | (m) | (m) | $608.00K | -$34.19M | $600.00K | $24.96M | (m) | (m) |
| 2019-12-31 | Rolling | (m) | -$46.97M* | (m) | (m) | (m) | (m) | (m) | (m) | $24.96M* | (m) | (m) |
| 2019-09-30 | Rolling | (m) | -$42.14M* | (m) | (m) | (m) | (m) | (m) | (m) | $23.45M* | (m) | (m) |
| 2019-06-30 | Rolling | (m) | -$41.15M* | (m) | (m) | (m) | (m) | (m) | (m) | $22.30M* | (m) | (m) |
| 2019-03-31 | Rolling | (m) | -$38.95M* | (m) | (m) | (m) | (m) | (m) | (m) | $19.92M* | (m) | (m) |
| 2018-12-31 | Reported | (m) | -$37.55M | (m) | (m) | (m) | $276.00K | -$23.90M | $600.00K | $17.25M | (m) | (m) |
| 2018-12-31 | Rolling | (m) | -$37.55M* | (m) | (m) | (m) | (m) | (m) | (m) | $17.25M* | (m) | (m) |
| 2018-09-30 | Rolling | (m) | -$37.30M* | (m) | (m) | (m) | (m) | (m) | (m) | $15.04M* | (m) | (m) |
| 2018-06-30 | Rolling | (m) | -$34.02M* | (m) | (m) | (m) | (m) | (m) | (m) | $12.92M* | (m) | (m) |
| 2018-03-31 | Rolling | (m) | -$31.04M* | (m) | (m) | (m) | (m) | (m) | (m) | $11.09M* | (m) | (m) |
| 2017-12-31 | Reported | (m) | -$25.57M | (m) | (m) | (m) | $2.55M | -$11.09M | $800.00K | $9.65M | (m) | (m) |
| 2017-12-31 | Rolling | (m) | -$25.57M* | (m) | (m) | (m) | (m) | (m) | (m) | $9.65M* | (m) | (m) |
| 2017-09-30 | Rolling | (m) | -$19.67M* | (m) | (m) | (m) | (m) | (m) | (m) | $8.43M* | (m) | (m) |
| 2017-06-30 | Rolling | (m) | -$14.95M* | (m) | (m) | (m) | (m) | (m) | (m) | $7.06M* | (m) | (m) |
| 2017-03-31 | Rolling | (m) | -$11.03M* | (m) | (m) | (m) | (m) | (m) | (m) | $6.36M* | (m) | (m) |
| 2016-12-31 | Reported | (m) | -$9.52M | (m) | (m) | (m) | $64.00K | -$8.05M | $500.00K | $5.51M | (m) | (m) |
| 2016-12-31 | Rolling | (m) | -$9.52M* | (m) | (m) | (m) | (m) | (m) | (m) | $5.51M* | (m) | (m) |
| 2016-09-30 | Rolling | (m) | -$8.24M* | (m) | (m) | (m) | (m) | (m) | (m) | $4.81M* | (m) | (m) |
| 2016-06-30 | Rolling | (m) | -$6.71M* | (m) | (m) | (m) | (m) | (m) | (m) | $3.91M* | (m) | (m) |
| 2016-03-31 | Rolling | (m) | -$5.41M* | (m) | (m) | (m) | (m) | (m) | (m) | $3.03M* | (m) | (m) |
| 2015-12-31 | Reported | (m) | -$4.47M | (m) | (m) | (m) | $86.00K | -$3.32M | (m) | $2.18M | (m) | -$1.66M |
| 2015-12-31 | Rolling | (m) | -$4.47M* | (m) | (m) | (m) | (m) | (m) | (m) | $2.58M* | (m) | -$1.66M* |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |